Why it was recalled
Failed Content Uniformity Specifications.
Product description
Tazorac (tazarotene) Gel 0.05%, 15 x 3.5g, sample packs, Allergan Inc, Irvine, CA 92612. UPC 300238335159
Lot numbers, UPCs & expiration codes
Lot #: 84126, Exp FEB/2017
Where it was sold
Nationwide and Puerto Rico
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-1065-2016
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- May 10, 2016
- FDA report date
- Jul 13, 2016
- Quantity
- N/A
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Allergan Sales, LLC
Original FDA data
Every field from FDA enforcement report D-1065-2016, exactly as published.
Show all FDA fields
- City
- Waco
- State
- TX
- Status
- Terminated
- Country
- United States
- Event ID
- 74126
- Address
- 8301 Mars Dr
- Code information
- Lot #: 84126, Exp FEB/2017
- Postal code
- 76712-6578
- Report date
- Jul 13, 2016
- Product type
- Drugs
- Recall number
- D-1065-2016
- Classification
- Class II
- Recalling firm
- Allergan Sales, LLC
- Termination date
- Dec 6, 2017
- Reason for recall
- Failed Content Uniformity Specifications.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Tazorac (tazarotene) Gel 0.05%, 15 x 3.5g, sample packs, Allergan Inc, Irvine, CA 92612. UPC 300238335159
- Distribution pattern
- Nationwide and Puerto Rico
- Recall initiation date
- May 10, 2016
- Initial firm notification
- Letter
- Center classification date
- Jul 6, 2016